Key Takeaways
- Q1 adjusted earnings per share came in at $0.99, falling short of the $1.05 analyst consensus
- Annual EPS forecast reduced to $4.80–$5.00 range from previous $4.95–$5.15 guidance
- Quarterly revenue reached $5.13 billion, surpassing the $5.03 billion expectation
- Shares plunged approximately 9% during premarket hours
- Management announced merger of two major divisions into single $14.6 billion business unit
GE HealthCare delivered weaker-than-anticipated first quarter results and reduced its annual earnings forecast, triggering a significant decline in share value during early Wednesday trading.
The medical technology company reported adjusted earnings of $0.99 per share for the period, falling $0.06 below analyst projections of $1.05. However, the top line showed strength—quarterly revenue hit $5.13 billion, representing a 7.4% year-over-year increase and exceeding the Street’s $5.03 billion forecast.
Operating margin performance disappointed as well, registering 13.5% versus expectations roughly one percentage point higher.
Shares tumbled approximately 9.6% to around $61.93 in premarket activity, compounding an already challenging year. The stock had already declined 16% year-to-date before Wednesday’s announcement.
GE HealthCare Technologies Inc., GEHC
Chief Executive Peter Arduini attributed the lowered outlook to accelerating cost pressures. The company experienced price increases across multiple categories including memory chips, petroleum products, and transportation services throughout the quarter. Arduini indicated the organization anticipates mitigating more than 50% of these inflationary headwinds through strategic pricing adjustments and efficiency initiatives.
Management revised its full-year adjusted earnings guidance downward to a $4.80–$5.00 range from the previously communicated $4.95–$5.15 target. The consensus estimate stood at $5.06. Despite the profit reduction, the company maintained its organic revenue growth projection of 3% to 4%.
First quarter order intake advanced 1.1%, while comparable revenue increased 2.9%.
Major Organizational Realignment
GE HealthCare unveiled plans to consolidate its two largest business divisions—imaging and advanced visualization solutions—into one integrated segment dubbed Advanced Imaging Solutions, representing a combined revenue footprint of $14.6 billion.
Phil Rackliffe, formerly leading the advanced visualization solutions division, will assume leadership of the newly formed combined segment. Roland Rott, the previous imaging division head, will depart the organization.
According to company statements, this consolidation aims to establish a more integrated imaging platform and unlock operational synergies.
Catherine Estrampes, who has spent 35 years with the organization, received appointment as Chief Commercial and Growth Officer and will oversee a newly established global markets region encompassing all territories excluding China.
Underperforming Its Spin-Off Siblings
GEHC has delivered the most disappointing returns among the trio of enterprises emerging from the legacy General Electric conglomerate. Following its January 2023 separation, shares have appreciated merely 13%, underperforming the S&P 500 by more than 70 percentage points during this timeframe.
In stark contrast, GE Aerospace has soared over 110% since the April 2024 corporate separation. GE Vernova has emerged as the clear winner, skyrocketing more than 675% during the comparable period.
GE Aerospace has capitalized on robust aircraft engine market demand. GE Vernova has benefited from accelerating investment in electricity generation infrastructure. GE HealthCare has confronted a more challenging operating landscape—soft demand dynamics, trade policy headwinds, and ongoing inflationary pressures.
The company does maintain a record order backlog approaching $22 billion as it entered 2026, which executives have highlighted as supporting future revenue visibility.
GEHC shares had gained just 1% over the trailing twelve-month period prior to Wednesday’s earnings release.





